Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation ...

DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and type 2 diabetes (T2D). Agonism of ...

T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 ...

Its annual Scientific Sessions set the agenda for clinical practice and research innovation. The 85th Scientific Sessions of ADA will be held in Chicago, U.S. from June 20 to 23, 2025. About ...

It has grown into one of the foremost nonprofit organizations in diabetes advocacy around the world. Its annual Scientific Sessions set the agenda for clinical practice and research innovation. The ...

Her Royal Highness The Princess Royal attended the 2025 Meet the Researcher Showcase, hosted by Medical Research Scotland at ...

A Lancaster County science fair champion has earned international honors for developing a fishing lure that won’t contribute ...

A Lancaster County science fair champion has earned international honors for developing a fishing lure that won’t contribute ...

The poster presented at the meeting will be made available on the Glucotrack website following the conference.